March 5, 2017
Vatican archbishop commissions himself into
March 5, 2017
Vatican archbishop commissions himself into a 'homoerotic' mural
By Matt C. Abbott
There are times when I wish a real news story was a fake news story.
This is one of those times.
From LifeSiteNews.com:
The archbishop now at the helm of the Pontifical Academy for Life paid a homosexual artist to paint a blasphemous homoerotic mural in his cathedral church….
The archbishop, Vincenzo Paglia, was also recently appointed by Pope Francis as president of the Pontifical Pope John Paul II Institute for Studies on Marriage and Family.
The massive mural … depicts Jesus carrying nets to heaven filled with naked and semi-nude homosexuals, transsexuals, prostitutes, and drug dealers, jumbled together in erotic interactions.
Included in one of the nets is Paglia …The image of the Savior is painted with the face of a local male hairdresser, and his private parts can be seen through his translucent garb….
n July of 2016, while still under the direction of Paglia, the Pontifical Council for the Family issued a new sex-ed program that includes lascivious and pornographic images so disturbing that one psychologist suggested that the archbishop be evaluated by a review board in accordance with norms of the Dallas Charter, which are meant to protect children from sexual abuse.
The Pontifical Academy for Life, whose mission was to help promote a culture of life and thereby help defeat the culture of death in which we live, was founded during the pontificate of the late Pope St. John Paul II.
Pope Francis has, for reasons unknown to most (including me), decided to gut “reform” the academy, much to the dismay of many pro-lifers. The academy technically still exists, with Paglia as its head.
Let’s face it. These prelates—and I include all modernist clergy in this statement—are not wolves in sheep’s clothing; they’re simply wolves (there are some notable exceptions, thank God). They blast President Trump, yet they have poisoned minds and souls in a far, far worse way than the president could ever dream of.
Sickening.
On a related front, the clergy sex abuse crisis, which has cost the Church over $2 billion since 2004, was/is due largely to pederasty. As Bill Donohue of the Catholic League pointed out: “78 percent of the males who were abused were postpubescent, and since all the victimizers were male, that means that homosexuality—not pedophilia—is at the root of the scandal.”
Certainly not politically correct to assert, but factual.
I should add that those who struggle with same-sex attraction but strive to live chaste lives deserve our moral support, just as those who struggle with other demons but strive to live morally upright lives deserve the same. < >
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Scrolling through these fresh stats from BrightLocal's recent report, you can almost hear the alarm bells echoing across small towns and city squares. The data paints a surprisingly sobering picture: despite the fact that 71% of folks are heading straight to Google to find local businesses, only a mere 22% of small business owners are tagging it as one of their top tools...
Continue Reading
Blending the Old with the New Here's an interesting tidbit for all you watch aficionados and investors: Casio is set to drop the GMC-2500 and GAC-2500, a new wave of G-SHOCK watches that are marrying that vintage cool with today's swagger. Straight out of Tokyo, these timepieces are taking a page from the 1983 DW-5000C playbook, but the twist? They're going analog. It's a...
Continue Reading
Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...
Continue Reading
RZ-001's European Success: A New Frontier Look, when a biopharmaceutical firm's RNA-editing therapy snags an Orphan Medicinal Product Designation from the European Commission, it's not just some clipboard milestone—it's a heavy-hitter move. That's exactly what Rznomics, the South Korean gene therapy player, pulled off with RZ-001. Now, we aren't just seeing paperwork...
Continue Reading
Lung Cancer's Unseen Struggles and a Ray of Hope Not every day we get a chance to chew on the news of another initiative by the American Lung Association. They're ringing the bell again this year, focusing on the underutilized biomarker testing that could be the ticket to a longer life for lung cancer patients. When you dive into the stark figures, it hits hard. More than...
Continue Reading
Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...
Continue Reading
Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...
Continue Reading
Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...
Continue Reading
Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...
Continue Reading
A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...
Continue Reading
Top 5 Most Recently Viewed Articles
Thumzup Media Corporation Announces Its Nasdaq Listing Thumzup Media Corporation, known for revolutionizing social media branding, has recently made a significant move by listing its shares on Nasdaq. This exciting development allows Thumzup (OTCQB: TZUP) to broaden its reach and enhance its visibility in the competitive landscape of digital marketing. The company's...
Continue Reading
Lumene Group Transforms Cyber Safety for Brand Protection Lumene Group has made significant advancements in its cybersecurity services in collaboration with Elisa. This innovative partnership focuses on protecting the company's brand integrity while actively monitoring for potential counterfeits. The updated cyber solutions include round-the-clock vigilance against cyber...
Continue Reading
J.B. Hunt Stock Target Upgraded Recently, Bernstein SocGen Group made an important adjustment to its stock price target for J.B. Hunt Transport Services (NASDAQ: JBHT). The new target is set at $184.00, just slightly higher than the previous figure of $182.00. Despite this modest increase, the firm maintains a Market Perform rating on the company's stock. Market Analysis...
Continue Reading
Home Helpers Home Care Achieves Prestigious Franchise Recognition Brand stands out among 75 franchises based on extensive research of over 35,000 franchise owners Home Helpers Home Care, a national leader in non-medical, in-home companionship and personal care services, has been honored with the title of one of the 2025 Most Profitable Franchises as recognized by...
Continue Reading
CSL's ANDEMBRY® Gains Approval in Canada Health Canada has officially approved ANDEMBRY® (garadacimab) as the first and only once-monthly treatment for hereditary angioedema (HAE). This crucial advancement marks a significant step forward for individuals grappling with HAE, a rare genetic condition that can lead to severe and unpredictable swelling attacks. A New Era...
Continue Reading